Group One Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Group One Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-441,700	Closed	-$7.76M	–	9203
2021 Q3	$7.76M	Buy	441,700 +277,800	+169%	+$3.25M	0.01%	1298
2021 Q2	$1.59M	Buy	163,900 +49,800	+44%	+$469K	﹤0.01%	2888
2021 Q1	$1.23M	Buy	114,100 +34,600	+44%	+$428K	﹤0.01%	2992
2020 Q4	$1.17M	Sell	79,500 -5,600	-7%	-$80.8K	﹤0.01%	2508
2020 Q3	$1.21M	Buy	85,100 +24,800	+41%	+$247K	﹤0.01%	2027
2020 Q2	$488K	Buy	60,300 +40,800	+209%	+$252K	﹤0.01%	2655
2020 Q1	$79K	Buy	+19,500	New	+$73.7K	﹤0.01%	3457
2018 Q4	–	Sell	-500	Closed	-$3K	–	5649
2018 Q3	$3K	Sell	500 -200	-29%	-$1.13K	﹤0.01%	4986
2018 Q2	$4K	Buy	700 +500	+250%	+$3.19K	﹤0.01%	4870
2018 Q1	$1K	Buy	+200	New	+$1.52K	﹤0.01%	4729

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Group One Trading's TRIL Position: Q4 2021 in Review

Group One Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 331,989 shares — an estimated $5.83M sold.

Group One Trading first reported a position in TRIL in Q1 2018 and held it in 10 quarters. The position peaked at $5.83M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Group One Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Group One Trading sold 331,989 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $5.83M.
Group One Trading first reported a position in Trillium Therapeutics Inc. in Q1 2018 and held it in 10 quarters.
Group One Trading's Trillium Therapeutics Inc. position peaked at $5.83M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.